Grandit (688549)

Search documents
中巨芯(688549) - 关于参加2025年半年度科创板半导体设备及材料行业集体业绩说明会的公告
2025-09-02 08:45
二、说明会召开的时间、地点和方式 证券代码:688549 证券简称:中巨芯 公告编号:2025-033 中巨芯科技股份有限公司 关于参加 2025 年半年度科创板半导体设备及 材料行业集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 一、说明会类型 中巨芯科技股份有限公司(以下简称"公司")已于 2025 年 8 月 27 日在上 海证券交易所网站(www.sse.com.cn)披露了《中巨芯科技股份有限公司 2025 年半年度报告》。为便于广大投资者更加全面深入地了解公司 2025 年半年度的 会议召开时间:2025 年 9 月 10 日(星期三)15:00-17:00 会议召开地点:上海证券交易所上证路演中心 (https://roadshow.sseinfo.com/) 会议召开方式:网络文字互动问答 会议问题征集:投资者可于 2025 年 9 月 3 日(星期三)至 9 月 9 日(星 期二)16:00 前登录上证路演中心网站首页,点击"提问预征集"栏目 (https://roa ...
中巨芯(688549) - 关于变更签字注册会计师的公告
2025-09-02 08:45
证券代码:688549 证券简称:中巨芯 公告编号:2025-034 中巨芯科技股份有限公司 关于变更签字注册会计师的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 中巨芯科技股份有限公司(以下简称"公司")于2025年4月9日、2025年5 月8日分别召开第二届董事会第六次会议、2024年年度股东大会,审议通过了 《关于续聘会计师事务所的议案》,同意聘请天健会计师事务所(特殊普通合 伙)(以下简称"天健所")为公司2025年度审计机构,具体内容详见公司于 2025年4月11日在上海证券交易所网站(www.sse.com.cn)披露的《关于续聘会 计师事务所的公告》(公告编号:2025-009)和公司于2025年5月9日在上海证 券交易所网站(www.sse.com.cn)披露的《2024年年度股东大会决议公告》 (公告编号:2025-016)。 近日,公司收到天健所出具的《关于变更签字注册会计师的函》,现将具 体情况公告如下: 一、本次变更基本情况 天健所作为公司聘任的2025年度审计机构,原委派签字注册会计师韦军 ...
中巨芯2025年中报简析:增收不增利,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-27 22:28
本次财报公布的各项数据指标表现一般。其中,毛利率11.47%,同比减20.14%,净利率1.03%,同比减 80.06%,销售费用、管理费用、财务费用总计2162.33万元,三费占营收比3.82%,同比增28.16%,每股 净资产2.05元,同比减0.37%,每股经营性现金流0.05元,同比增86.75%,每股收益0.01元,同比减 64.52% 据证券之星公开数据整理,近期中巨芯(688549)发布2025年中报。截至本报告期末,公司营业总收入 5.67亿元,同比上升20.4%,归母净利润813.77万元,同比下降64.57%。按单季度数据看,第二季度营 业总收入2.96亿元,同比上升24.95%,第二季度归母净利润932.15万元,同比下降39.41%。本报告期中 巨芯公司应收账款体量较大,当期应收账款占最新年报归母净利润比达2757.46%。 证券之星价投圈财报分析工具显示: 业务评价:去年的净利率为1.09%,算上全部成本后,公司产品或服务的附加值不高。从历史年报数据 统计来看,公司上市以来中位数ROIC为-0.02%,投资回报极差,其中最惨年份2018年的ROIC 为-5.27%,投资回报极差。公司 ...
8月27日晚间重要公告一览
Xi Niu Cai Jing· 2025-08-27 10:16
Group 1 - Youyou Food achieved a net profit of 108 million yuan in the first half of 2025, a year-on-year increase of 42.47%, with a revenue of 771 million yuan, up 45.59% [1] - Keda achieved a net profit of 255 million yuan, a year-on-year increase of 16.49%, with a revenue of 2.163 billion yuan, up 14.35% [1] - North Navigation turned a profit with a net profit of 116 million yuan, achieving a revenue of 1.703 billion yuan, a year-on-year increase of 481.19% [1][2] Group 2 - China Satellite Communication reported a net profit of 181 million yuan, a year-on-year decrease of 55.59%, with a revenue of 1.221 billion yuan, up 6.33% [3] - Huqin Technology achieved a net profit of 1.889 billion yuan, a year-on-year increase of 46.3%, with a revenue of 83.939 billion yuan, up 113.06% [4] - Huasen Lithium reported a net loss of 72.739 million yuan, with a revenue of 350 million yuan, up 72.02% [4] Group 3 - Putailai achieved a net profit of 1.055 billion yuan, a year-on-year increase of 23.03%, with a revenue of 7.088 billion yuan, up 11.95% [5] - Suochen Technology reported a net loss of 45.698 million yuan, with a revenue of 57.351 million yuan, up 10.82% [5] - Canqin Technology achieved a net profit of 51.912 million yuan, a year-on-year increase of 51.94%, with a revenue of 287 million yuan, up 52.76% [6] Group 4 - Hengtong achieved a net profit of 99.3648 million yuan, a year-on-year increase of 38.86%, with a revenue of 669 million yuan, down 44.66% [6] - Sanan Optoelectronics reported a net profit of 176 million yuan, a year-on-year decrease of 4.24%, with a revenue of 8.987 billion yuan, up 17.03% [7] - New Dairy achieved a net profit of 397 million yuan, a year-on-year increase of 33.76%, with a revenue of 5.526 billion yuan, up 3.01% [8] Group 5 - Yiling Pharmaceutical achieved a net profit of 669 million yuan, a year-on-year increase of 26.03%, with a revenue of 4.040 billion yuan, down 12.26% [10] - Baosteel achieved a net profit of 4.879 billion yuan, a year-on-year increase of 7.36%, with a revenue of 151.372 billion yuan, down 7.28% [12] - Feikai Materials achieved a net profit of 217 million yuan, a year-on-year increase of 80.45%, with a revenue of 1.462 billion yuan, up 3.8% [13] Group 6 - Lier Chemical achieved a net profit of 271 million yuan, a year-on-year increase of 191.21%, with a revenue of 4.507 billion yuan, up 35.36% [15] - Shaanxi Coal achieved a net profit of 7.638 billion yuan, a year-on-year decrease of 31.18%, with a revenue of 779.83 billion yuan, down 14.19% [16] - Dongfang Materials reported a net profit of 654,400 yuan, a year-on-year decrease of 88.48%, with a revenue of 174 million yuan, down 5.06% [18] Group 7 - Blue Sky Bio achieved a net profit of 26.7163 million yuan, a year-on-year decrease of 8.98%, with a revenue of 652 million yuan, up 7.05% [19] - Shanghai Jiubai achieved a net profit of 23.7897 million yuan, a year-on-year increase of 0.24%, with a revenue of 45.0535 million yuan, down 1.09% [20] - Two Sides Needle reported a net loss of 5.0842 million yuan, with a revenue of 522 million yuan, up 1.02% [21] Group 8 - Shanghai Yashi achieved a net profit of 20.3263 million yuan, a year-on-year increase of 42.56%, with a revenue of 2.044 billion yuan, up 56.75% [23] - Bayi Steel reported a net loss of 697 million yuan, with a revenue of 8.733 billion yuan, down 6.73% [25] - Hongrun Construction plans to repurchase shares worth between 150 million and 300 million yuan [27] Group 9 - Kaile achieved a net profit of 10.9193 million yuan, a year-on-year increase of 280.42%, with a revenue of 137 million yuan, down 17.89% [28] - Jingda achieved a net profit of 306 million yuan, a year-on-year increase of 6.03%, with a revenue of 11.856 billion yuan, up 14.28% [29] - Blue Light Marker reported a net profit of 96.4427 million yuan, a year-on-year decrease of 47.33%, with a revenue of 32.36 billion yuan, up 4.87% [30] Group 10 - KOTAI Power achieved a net profit of 23.994 million yuan, a year-on-year increase of 35.52%, with a revenue of 711 million yuan, up 49.51% [33] - Bo Rui Data reported a net loss of 26.1918 million yuan, with a revenue of 70.1997 million yuan, up 5.19% [34] - Jiuzhoutong achieved a net profit of 1.446 billion yuan, a year-on-year increase of 19.7%, with a revenue of 81.106 billion yuan, up 5.10% [37] Group 11 - Aier Eye Hospital achieved a net profit of 2.051 billion yuan, a year-on-year increase of 0.05%, with a revenue of 11.507 billion yuan, up 9.12% [39] - Nandu Property achieved a net profit of 130 million yuan, a year-on-year increase of 532.87%, with a revenue of 914 million yuan, up 2.75% [41] - Weiyuan reported a net loss of 168 million yuan, with a revenue of 4.601 billion yuan, up 1.82% [42] Group 12 - Zhongke Chuangda achieved a net profit of 158 million yuan, a year-on-year increase of 51.84%, with a revenue of 3.299 billion yuan, up 37.44% [43] - Zhongjuxin reported a net profit of 8.1377 million yuan, a year-on-year decrease of 64.57%, with a revenue of 567 million yuan, up 20.40% [44] - Inspur Information achieved a net profit of 799 million yuan, a year-on-year increase of 34.87%, with a revenue of 80.192 billion yuan, up 90.05% [45] Group 13 - Shenghong Technology achieved a net profit of 2.143 billion yuan, a year-on-year increase of 366.89%, with a revenue of 9.031 billion yuan, up 86.00% [46] - Cambrian achieved a net profit of 1.038 billion yuan, turning a profit, with a revenue of 2.881 billion yuan, up 4347.82% [48] - Longteng Optoelectronics reported a net loss of 121 million yuan, with a revenue of 1.289 billion yuan, down 27.91% [49]
中巨芯H1营收5.67亿元,Q2利润环比转正
Ju Chao Zi Xun· 2025-08-27 10:01
8月26日晚,中巨芯发布2025年上半年报告称,上半年,公司实现营业总收入5.67亿元,同比增长20.4%;归属于上市公司股东 的净利润813.77万元,同比下降64.57%;扣除非经常性损益的净利润为96.92万元,同比下降92.24%。其中,第二季度实现归属 于上市公司股东的净利润环比扭亏为盈。 | | | | 早征: 兀 中: 人民巾 | | --- | --- | --- | --- | | 主要会计数据 | 本报告期 | 上年同期 | 本报告期比上年 | | | (1-6月) | | 同期增减(%) | | 营业收入 | 566.566.646.39 | 470,569,562.96 | 20.40 | | 利润息额 | 5.478.923.39 | 27.547.167.54 | -80.11 | | 归属于上市公司股东的净利润 | 8.137.661.54 | 22.966.908.51 | -64.57 | | 归属于上市公司股东的扣除非经常性 损益的净利润 | 969 199 85 | 12.484.176.92 | -92.24 | | 经营活动产生的现金流量净额 | 77.122.969 ...
中巨芯(688549):产销并进拓疆土,二季度环比扭亏为盈
CMS· 2025-08-27 07:36
Investment Rating - The report maintains an "Accumulate" investment rating for the company [3][7]. Core Views - The company achieved a total revenue of 567 million yuan in the first half of 2025, representing a year-on-year increase of 20.40%. However, the net profit attributable to shareholders decreased by 64.57% year-on-year to 8.14 million yuan due to market conditions and increased competition [1][7]. - The electronic wet chemical segment generated revenue of 434.15 million yuan, up 25.57% year-on-year, while the electronic specialty gases and precursors segment saw revenue of 120.42 million yuan, a 10.49% increase year-on-year [7]. - The company is focusing on R&D, with R&D expenses amounting to 40.60 million yuan, which is 7.17% of total revenue, reflecting a 38.70% increase year-on-year [7]. - The company is expected to achieve revenues of 1.29 billion yuan, 1.62 billion yuan, and 1.95 billion yuan in 2025, 2026, and 2027 respectively, with year-on-year growth rates of 26%, 25%, and 20% [7][8]. Financial Data and Valuation - The company’s total revenue is projected to grow from 894 million yuan in 2023 to 1.95 billion yuan in 2027, with corresponding year-on-year growth rates of 12%, 15%, 26%, 25%, and 20% [2][10]. - The net profit attributable to shareholders is expected to increase from 14 million yuan in 2023 to 24 million yuan in 2027, with growth rates of 30%, -27%, 21%, 53%, and 31% respectively [8][11]. - The company’s PE ratios for 2025, 2026, and 2027 are projected to be 1100.2, 718.1, and 548.1 respectively, indicating a valuation above the industry average [7][11]. Stock Performance - The company's stock has shown a 14% absolute performance over the past month, a -1% performance over six months, and a 58% performance over the past year [5].
中巨芯拟使用13.5亿元闲置资金进行现金管理
Xin Lang Cai Jing· 2025-08-26 14:21
Core Viewpoint - The company has approved the use of temporarily idle raised funds and self-owned funds for cash management, with a total maximum amount of 1.35 billion yuan [1][4]. Fundraising and Usage - On June 13, 2023, the company received approval from the China Securities Regulatory Commission for its initial public offering, raising a total of 1.913 billion yuan, with a net amount of 1.807 billion yuan after deducting issuance costs [2]. - As of June 30, 2025, the company has disclosed the usage of raised funds in its special report [2]. Previous Cash Management Situation - On September 26, 2024, the company approved the use of up to 1 billion yuan of temporarily idle raised funds and up to 400 million yuan of self-owned funds for cash management, with a validity period of 12 months [3]. Current Cash Management Details - The purpose of the current cash management is to improve the efficiency of using raised and self-owned funds while ensuring the safety of funds and the implementation of investment projects [4]. - The maximum amount for temporarily idle raised funds is set at 750 million yuan, and for self-owned funds, it is 600 million yuan, with a validity period of 12 months starting from September 25, 2025 [4]. - The funds will be used to purchase low-risk cash management products with high safety and liquidity, and the income will be prioritized for supplementing investment amounts and daily operational liquidity [4]. Impact on the Company and Risk Control - The company states that the cash management will not affect the implementation of investment plans and will enhance fund usage efficiency, benefiting both the company and its shareholders [5]. - Various risk control measures will be implemented, including selecting appropriate investment products and adhering to strict disclosure obligations [5].
中巨芯(688549) - 国泰海通证券股份有限公司关于中巨芯科技股份有限公司放弃优先购买权暨关联交易的核查意见
2025-08-26 13:38
国泰海通证券股份有限公司 关于中巨芯科技股份有限公司 放弃优先购买权暨关联交易的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐人")作为中 巨芯科技股份有限公司(以下简称"中巨芯"或"公司")首次公开发行股票并 上市持续督导的保荐人,根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所上市公司自律监管指引第 11 号— —持续督导》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运 作》等相关法律、法规和规范性文件的规定,对中巨芯放弃优先购买权暨关联 交易的事项进行了核查,核查情况与意见如下: 一、关联交易概述 为更好地实施战略规划及支持日常经营和业务发展,中巨芯持有 49.81%股 权的重要参股子公司晶恒希道(上海)科技有限公司(以下简称"晶恒希道") 拟通过增资扩股方式引入投资者上海盛芯腾接力私募基金合伙企业(有限合伙) (以下简称"盛芯腾"),盛芯腾拟以现金方式出资人民币 1,800 万元认缴晶恒希 道新增注册资本 1,800 万元。公司、徐州盛芯半导体产业投资基金合伙企业(有 限合伙)(以下简称"盛芯基金")和宁波云德半导体材料有限公 ...
中巨芯(688549) - 国泰海通证券股份有限公司关于中巨芯科技股份有限公司继续使用暂时闲置募集资金(含超募资金)和自有资金进行现金管理的核查意见
2025-08-26 13:38
国泰海通证券股份有限公司 关于中巨芯科技股份有限公司继续使用暂时闲置募集资金 (含超募资金)和自有资金进行现金管理的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐人")作为中 巨芯科技股份有限公司(以下简称"中巨芯"、"公司"或"发行人")首次公开 发行股票并在科创板上市的保荐人,根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管 指引第 1 号——规范运作》《上海证券交易所上市公司自律监管指引第 11 号—— 持续督导》《上市公司募集资金监管规则》等有关法律法规和规范性文件的要求, 就中巨芯继续使用暂时闲置募集资金(含超募资金)和自有资金进行现金管理的 事项进行了审慎核查,并发表如下核查意见: 一、募集资金基本情况 截至 2025 年 6 月 30 日,公司募投项目及募集资金使用情况详见公司于 2025 年 8 月 27 日披露于上海证券交易所网站(www.sse.com.cn)的《中巨芯科技股 份有限公司 2025 年半年度募集资金存放、管理与实际使用情况的专项报告》(公 告编号:2025-024)。 三、前次使用暂时闲置募集 ...
中巨芯(688549) - 国泰海通证券股份有限公司关于中巨芯科技股份有限公司全资子公司之间吸收合并暨变更部分募投项目实施主体的核查意见
2025-08-26 13:38
国泰海通证券股份有限公司 关于中巨芯科技股份有限公司全资子公司之间吸收合并暨 变更部分募投项目实施主体的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐人")作为中 巨芯科技股份有限公司(以下简称"中巨芯"、"公司"或"发行人")首次公开 发行股票并在科创板上市的保荐人,根据《证券发行上市保荐业务管理办法》《上 市公司募集资金监管规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上海证券交易所科创板股票上市规则》等有关法律法规和规 范性文件的要求,对中巨芯全资子公司之间吸收合并暨变更部分募投项目实施主 体的事项进行了核查,核查情况如下: 一、吸收合并双方基本情况 2、公司类型:有限责任公司(非自然人投资或控股的法人独资) 3、注册资本:人民币 30,000 万元 4、法定代表人:明博 (一)吸收合并方基本情况 5、公司住址:衢州市高新技术产业园区念化路 8 号 1、公司名称:浙江凯圣氟化学有限公司(以下简称"凯圣氟化学") 6、成立日期:2003 年 6 月 6 日 1、公司名称:中巨芯(衢州)科技有限公司(以下简称"中巨芯(衢州)") 1 9、公司股权结构:中巨芯持有 ...